View Post

Researchers advocate new approach to breast cancer prevention

In Clinical Studies News by Barbara Jacoby

By: Mayo Clinic From: medicalxpress.com A commentary by Mayo Clinic Cancer Center researchers published in the Journal of Clinical Oncology Practice suggests that advances in breast cancer prevention research have resulted in new and innovative opportunities to modify breast cancer risk and potentially reduce breast cancer incidence and mortality. “It is prudent for health care providers to be knowledgeable about …

View Post

Turmeric supplements not proven as safe in breast cancer treatment

In In The News by Barbara Jacoby

By: Dawn Mussallem, D.O., Tribune Content Agency From: news8000.com DEAR MAYO CLINIC: I recently was diagnosed with breast cancer, and I will have surgery followed by chemotherapy. A friend told me that turmeric has anti-cancer properties. I have taken turmeric supplements in the past for osteoarthritis. Can you tell me more about turmeric and if I can safely take it …

View Post

Mayo Clinic research suggests women over 65 be offered hereditary cancer genetic testing

In In The News by Barbara Jacoby

Source: Mayo Clinic From: eurekalert.org A new study by Fergus Couch, Ph.D., of Mayo Clinic Cancer Center, along with collaborators from the CARRIERS consortium, suggests that most women with breast cancer diagnosed over 65 should be offered hereditary cancer genetic testing. The study was published Thursday, July 22, in the Journal of Clinical Oncology. Dr. Couch says that women over …

View Post

Mayo Clinic Minute: Using targeted therapy to treat breast cancer

In In The News by Barbara Jacoby

By: Deedee Stiepan From: medicalxpress.com Proton therapy is a newer type of radiation therapy that uses energy from positively charged particles called protons. Studies have suggested that proton therapy may cause fewer side effects than traditional radiation, since doctors can better control where the proton beams deposit their energy. In this Mayo Clinic Minute, Dr. Robert Mutter, a Mayo Clinic …

View Post

Study updates breast cancer risk estimates for women with no family history

In Clinical Studies News by Barbara Jacoby

Source: Mayo Clinic From: eurekalert.org A new multi-institution study led by Fergus Couch, Ph.D., a Mayo Clinic pathologist, provides more accurate estimates of breast cancer risk for U.S. women who harbor inherited mutations in breast cancer predisposition genes. The findings of the CARRIERS Consortium study, which were published Wednesday, Jan. 20 in the New England Journal of Medicine, may allow …

View Post

Mayo Researchers: Change NCCN Criteria to Expand Genetic Testing in Breast Cancer

In In The News by Barbara Jacoby

By: Jason M. Broderick From: onclive.com Researchers at the Mayo Clinic maintain that all women aged 65 or under with a breast cancer diagnosis should receive germline genetic testing to identify harmful mutations that increase both their risk of developing secondary cancers and their blood relatives’ risk of developing cancer.1 The researchers published a study in the Journal of Clinical …

View Post

Mayo researchers recommend all women with breast cancer diagnosis under age 66 be offered genetic testing

In In The News by Barbara Jacoby

Source: Tribune Content Agency From: gmtoday.com A study by researchers at Mayo Clinic published this week in the Journal of Clinical Oncology suggests that all women with a breast cancer diagnosis under the age of 66 be offered germline genetic testing to determine if they have a gene mutation known to increase the risk of developing other cancers and cancers …

View Post

Transgene and NEC Start Two Clinical Trials with TG4050, an Individualized AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers

In Clinical Studies News by Barbara Jacoby

From: businesswire.com TG4050 moves therapeutic vaccination into the digital age: combines Transgene’s expertise in viral vectors with NEC’s cutting-edge Artificial Intelligence (AI) capabilities Novel immunotherapy is fully tailored to each individual by generating an immune response that targets highly specific patient tumor mutations First patients enrolled in two Phase 1 trials at the Mayo Clinic and Toulouse Oncopole Transgene (Paris:TNG) …

View Post

Women at Elevated Risk of Developing Breast Cancer May Benefit From Taking Anti-inflammatory Drugs

In In The News by Barbara Jacoby

Source: Mayo Clinic Research from Mayo Clinic investigators suggest that some women with an elevated risk of developing breast cancer may benefit from taking anti-inflammatory medications. “Several studies have evaluated whether the use of anti-inflammatory medications such as aspirin, ibuprofen and naproxen affect a woman’s risk of developing breast cancer,” says Amy Degnim, M.D., a breast surgical oncologist at Mayo …

View Post

Study finds new way to make chemotherapy more effective against pancreatic cancer

In Clinical Studies News by Barbara Jacoby

By: Jay Furst From: mayoclinic.org Pancreatic adenocarcinoma (PDAC) is a lethal malignancy that most often is resistant to chemotherapy. Researchers have been searching for ways to increase the sensitivity of the tumors to cancer-fighting drugs. A Mayo Clinic-led study published today opens a promising new front in that battle. Using patient cell lines and tumor-bearing models, researchers found that inhibition …